Disc Medicine Inc. (IRON)
NASDAQ: IRON
· Real-Time Price · USD
62.96
0.46 (0.74%)
At close: Sep 26, 2025, 11:05 AM
0.74% (1D)
| Bid | 62.73 |
| Market Cap | 2.19B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -145.39M |
| EPS (ttm) | -4.46 |
| PE Ratio (ttm) | -14.12 |
| Forward PE | -9.51 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 63.11 |
| Volume | 40,896 |
| Avg. Volume (20D) | 349,649 |
| Open | 62.40 |
| Previous Close | 62.50 |
| Day's Range | 61.97 - 63.30 |
| 52-Week Range | 30.82 - 68.73 |
| Beta | 2.50 |
| Ex-Dividend Date | n/a |
About IRON
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IRON
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IRON stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts10 months ago
+11.21%
Disk Medicine shares are trading higher. HC Wainwr...
Unlock content with
Pro Subscription
10 months ago
+23.59%
Disc Medicine shares are trading higher after the company announced the end of its Phase 2 Bitopertin In Erythropoietic Protoporphyria meeting with the FDA. The company is aligned with the FDA across all proposed study parameters and has a clear development path to registration.
